me Open to everyone
Embed:
Loading Portfolio...
| id | rsymbol | Symbol | Current Price | Change (%) | Open | High | Low | Volume | Date Added | Cost per share | Quantity | Value | Value Weighting | Gain (%) | Gain ($) | Fair Value ($) | Note | Company | Exchange | Industry | Market Cap ($M) | Sales ($M) | Book Value | Debt to Equity | Yield | Payout | 10-Y Dividend Payout Range | Financial Strength | Profitability | Interest Coverage | 52-W Range | 1-W Change (%) | 4-W Change (%) | 52-W Change (%) | YTD Change (%) | Beta | Short Ratio | P/E | P/S | P/B | 10-Year P/E Range | 10-Year P/S Range | 10-Year P/B Range | PEG | 1-Year Revenue Growth Rate | 5-Year Revenue Growth Rate | 10-Year Revenue Growth Rate | 1-Year EBITDA Growth Rate | 5-Year EBITDA Growth Rate | 10-Year EBITDA Growth Rate | NCAV | Median PS Value | Graham Number | Peter Lynch Fair Value | Earnings Yield | Forward Rate of Return | Shiller P/E | EV/EBIT | EV/EBITDA | Predictability Rank | Operating Margin | Net Margin | Cash per Share | ROE | ROA | Altman Z Score | Piotroski F Score | Beneish M Score | EV/Sales |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 429481 | ABT | ABT | 37.48 | -0.24 (-0.64%) | 37.49 | 37.86 | 37.30 | 7.1M | 11/09/2012 | 64.93 | 0 | 0.00 | 0% | -42.28% | 0.00 | Add | Abbott Laboratories | NYSE(USA) | Drug Manufacturers - Major | 58800.4 | 39873.9 | 17.02 | 0.49 | 3.47 | 0.5046 | 0.388 1.038 |
55.4 | 77.7 | 15.8 | 28.45 38.77 |
1.76 | 0.73 | 32.07 | 20.48 | 0.33 | 185 | 11.33 | 1.49 | 2.20 | 5.78 28.44 |
0.96 2.76 |
1.39 4.55 |
1.5 | -9.8 | 8.1 | 9.1 | -0 | 7.6 | 10.3 | 4.83 | 34.63 | 11.17 | 21.56 | 12.50 | 15.78 | 11.4 | 8 | 6.26 |
![]()
Back Testing Results: Average gain of all 3.5-Star stocks: 9.3% per year. % of Stocks that are in still loss if held for 10yrs: 9%. Read more: What is Predictability Rank? Performances of real portfolio Top Ranked Predictable Companies |
20.30 | 15 | -16.13 | 22.3 | 8.9 | 2.44 | 0 | 0 | -0.13 | |
| 429482 | NSC | NSC | 77.45 | -0.38 (-0.49%) | 77.00 | 77.67 | 76.20 | 2.5M | 11/09/2012 | 58.76 | 0 | 0.00 | 0% | 31.81% | 0.00 | Add | Norfolk Southern Corporation | NYSE(USA) | Railroads | 24523.3 | 10989 | 31.03 | 0.75 | 2.58 | 0.3543 | 0.154 1.778 |
48.5 | 86 | 6.3 | 56.05 81 |
-2.37 | 2.78 | 16.68 | 26.86 | 1.06 | 215 | 13.93 | 2.27 | 2.50 | 6.46 50 |
0.79 2.82 |
0.8 2.76 |
1.6 | 3.6 | 8.1 | 7.3 | 0.6 | 8.5 | 10.6 | 2.79 | 66.16 | 60.26 | 46.25 | 9.50 | 11.35 | 16.5 | 10.5 | 8.26 |
![]()
Back Testing Results: Average gain of all 4-Star stocks: 9.8% per year. % of Stocks that are in still loss if held for 10yrs: 8%. Read more: What is Predictability Rank? Performances of real portfolio Top Ranked Predictable Companies |
28.30 | 15.8 | -63.32 | 17.9 | 5.8 | 1.77 | 5 | -2.36 | -0.73 | |
| Summary | -0.31 (-0.57%) | 0.00 | -5.24% | 0.00 | 12.63 | 1.88 | 2.35 | 12.63 | 1.88 | 2.35 |



RSS